Metabolism of a 5-nitroimidazole in susceptible and resistant isogenic strains of Bacteroides fragilis

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1495-1499

  Carlier, Jean Philippe ^a   Sellier, Nicole ^b   Rager, Marie Noëlle ^c   Reysset, Gilles ^a  

^a INSTITUT PASTEUR   (France)

^b PSL RESEARCH UNIVERSITY   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 NITRONAPHTHOFURAN; 2 NITRONAPHTHO[1,2 B]FURAN; 4 NITROIMIDAZOLE; 4 NITROIMIDAZOLE DERIVATIVE; 7 METHOXY 2 NITRONAPHTHO[2,1 B]FURAN; CHLORAMPHENICOL; DIMETRIDAZOLE; FURAZOLIDONE; METRONIDAZOLE; NITROFURAL; NITROFURAN DERIVATIVE; NITROFURANTOIN; ORNIDAZOLE; SECNIDAZOLE; TINIDAZOLE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTEROIDES FRAGILIS; DRUG METABOLISM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0030748173     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1495     Document Type: Article

References (23)

1. Barnes, A. R., and D. J. Makohon. 1993. Correlation of degradation in metronidazole infusion with FO applied during steam sterilization at 122°C. Int. J. Pharm. 92:233-276.
2. Chrystal, E. J. T., R. L. Koch, and P. Goldman. 1980. Metabolites from the reduction of metronidazole by xanthine oxidase. Mol. Pharmacol. 18:105-111.
3. Edwards, D. I. 1986. Mode of action of 5-nitroimidazoles. Acta Univ. Carol. Biol. 30:471-483.
4. Edwards, D. I. 1993. Nitroimidazole drugs - action and resistance mechanisms. I. Mechanisms of action. J. Antimicrob. Chemother. 31:9-20.
5. Ehlhardt, W. J., B. B. Beaulieu, Jr., and P. Goldman. 1987. Formation of an amino reduction product of metronidazole in bacterial cultures: lack of bactericidal activity. Biochem. Pharmacol. 36:259-264.
6. Gorontzy, T., J. Küver, and K. H. Blotevogel. 1993. Microbial transformation of nitroaromatic compounds under anaerobic conditions. J. Gen. Microhiol. 139:1331-1336.
7. Harrison, A. G. 1992. Chemical ionization mass spectrometry, p. 73-75. In Chemical ionization reagent ion systems. CRC Press, Inc., Boca Raton, Fla.
8. Josephy, P. D., B. Palcic, and L. D. Skarsgard. 1979. Synthesis and properties of reduced derivatives of misonidazole, p. 61-64. In L. W. Brady (ed.), Radiation sensitizers. Masson, New York, N.Y.
9. Kinouchi, T., and Y. Ohnishi. 1983. Purification and characterization of 1-nitropyrene nitroreductases from Bacteroides fragilis. Appl. Environ. Microbiol. 46:596-604.
10. Knox, R. J., R. C. Knight, and D. I. Edwards. 1983. Studies on the action of nitroimidazole drugs. The products of nitroimidazole reduction. Biochem. Pharmacol. 32:2149-2156.
11. Knox, R. J., D. I. Edwards, and R. C. Knight. 1984. The mechanism of nitroimidazole damage to DNA: coulometric evidence. Int. J. Radiat. Oncol. Biol. Phys. 10:1315-1318.
12. Koch, R. L., E. J. T. Chrystal, B. B. Beaulieu, Jr., and P. Goldman. 1979. Acetamide - a metabolite of metronidazole formed by the intestinal flora. Biochem. Pharmacol. 28:3611-3615.
13. LaRusso, N. F., M. Tomasz, M. Müller, and R. Lipman. 1977. Interaction of metronidazole with nucleic acids in vitro. Mol. Pharmacol. 13:872-882.
14. Lin, Y. Y., and L. L. Smith. 1979. Active hydrogen by chemical ionization mass spectrometry. Biomed. Mass Spectrom. 6:15-18.
15. Midha, K. K., J. McGilveray, and J. K. Cooper. 1973. Determination of therapeutic levels of metronidazole in plasma by gas-liquid chromatography. J. Chromatogr. 87:491-497.
16. Moore, S., and W. H. Stein. 1954. A modified ninhydrin reagent for the photometric determination of amino acids and related compounds. J. Biol. Chem. 211:907-913.
17. Privitera, G., A. Dublanchet, and M. Sebald. 1979. Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis. J. Infect. Dis. 139:97-101.
18. Reysset, G., A. Haggoud, W. J. Su, and M. Sebald. 1992. Genetic and molecular analysis of pIP417 and pIP419: Bacteroides plasmids encoding 5-nitroimidazole resistance. Plasmid 27:181-190.
19. Reysset, G. 1996. Genetics of 5-nitroimidazole resistance in Bacteroides species. Anaerobe 2:59-69.
20. Royer, R., J. P. Buisson, and L. René. 1978. Recherches sur les dérivés nitrés d'intérêt biologique. XIV. Activités contre les microorganismes des benzologues et furologues du nitro-2 benzofuranne. Eur. J. Med. Chem. 13:407-409.
21. Royer, R., and J. P. Buisson. 1980. Recherches sur les dérivés nitrés d'intérêt biologique. XX. Modalités de synthèse des dérivés méthoxylés ou halogénés de nitro-2 furannes. Eur. J. Med. Chem. 15:275-278.
22. Smith, C. J. 1985. Development and use of cloning systems for Bacteroides fragilis: cloning of a plasmid-encoding clindamycin resistance determinant. J. Bacteriol. 164:294-301.
23. Sullivan, C. E., F. P. Tally, B. R. Goldin, and P. Vouros. 1982. Synthesis of 1-(2-hydroxyethyl)-2-methyl-5-aminoimidazole: a ring-intact reduction product of metronidazole. Biochem. Pharmacol. 31:2689-2691.